Urinary Retention in Adults: Evaluation and Initial Management

 

Am Fam Physician. 2018 Oct 15;98(8):496-503.

Author disclosure: Dr. Stoffel reports receiving grant funding from Ipsen and Cogentix in relation to treatment of neurogenic overactive bladder and stress incontinence; the other authors have no relevant financial affiliations.

Urinary retention is the acute or chronic inability to voluntarily pass an adequate amount of urine. The condition predominantly affects men. The most common causes are obstructive in nature, with benign prostatic hyperplasia accounting for 53% of cases. Infectious, inflammatory, iatrogenic, and neurologic causes can also affect urinary retention. Initial evaluation should involve a detailed history that includes information about current prescription medications and use of over-the-counter medications and herbal supplements. A focused physical examination with neurologic evaluation should be performed, and diagnostic testing should include measurement of postvoid residual (PVR) volume of urine. There is no consensus regarding a PVR-based definition for acute urinary retention; the American Urological Association recommends that chronic urinary retention be defined as PVR volume greater than 300 mL measured on two separate occasions and persisting for at least six months. Initial management of urinary retention involves assessment of urethral patency with prompt and complete bladder decompression by catheterization. Suprapubic catheters improve patient comfort and decrease bacteriuria and the need for recatheterization in the short term; silver alloy–coated and antibiotic-impregnated catheters offer clinically insignificant or no benefit. Further management is decided by determining the cause and chronicity of the urinary retention and can include initiation of alpha blockers with voiding trials. Patients with urinary retention related to an underlying neurologic cause should be monitored in conjunction with neurology and urology subspecialists.

Urinary retention is the inability to voluntarily pass an adequate amount of urine and can be attributable to acute and chronic etiologies. Acute urinary retention is a urologic emergency characterized by the sudden inability to urinate combined with suprapubic pain, bloating, urgency, distress, or, occasionally, mild incontinence.1 Chronic urinary retention is usually associated with non-neurogenic causes, is often asymptomatic, and lacks consensus on defining criteria. The overall incidence of urinary retention is much higher in men than women and increases dramatically as men age. Estimates for men range from 4.5 to 6.8 per 1,000 person-years, increasing up to 300 per 1,000 person-years for men in their 80s, whereas the incidence in women is only seven per 100,000 per year.24

 Enlarge     Print

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationEvidence ratingReferences

Initial evaluation of the patient with suspected urinary retention should involve a detailed history, including current use of prescription and over-the-counter medications and herbal supplements.

C

5

A focused physical examination, including a neurologic evaluation, should be performed in patients with suspected urinary retention, and diagnostic testing should include measurement of postvoid residual urine volume.

C

5

Suprapubic catheters improve patient comfort and decrease bacteriuria and the need for recatheterization in patients requiring catheterization for up to 14 days.

A

29

Silver alloy–coated and antibiotic-impregnated urethral catheters are not recommended for use in patients with suspected urinary retention because neither produces significantly positive results.

A

31

In patients with urinary retention, initiation of alpha-blocker therapy at the time of catheter insertion or at least before removal is suggested because alpha blockers improve the likelihood of a successful voiding trial.

A

3537


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

SORT: KEY RECOMMENDATIONS FOR PRACTICE

Clinical recommendationEvidence ratingReferences

Initial evaluation of the patient with suspected urinary retention should involve a detailed history, including current use of prescription and over-the-counter medications and herbal supplements.

C

5

A focused physical examination, including a neurologic evaluation, should be performed in patients with suspected urinary retention, and diagnostic testing should include measurement of postvoid residual urine volume.

C

5

Suprapubic catheters improve patient comfort and decrease bacteriuria and the need for recatheterization in patients requiring catheterization for up to 14 days.

A

29

Silver alloy–coated and antibiotic-impregnated urethral catheters are not recommended for use in patients with suspected urinary retention because neither produces significantly positive results.

A

31

In patients with urinary retention, initiation of alpha-blocker therapy at the time of catheter insertion or at least before removal is suggested because alpha blockers improve the likelihood of a successful voiding trial.

A

3537


A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.

Causes of Urinary Retention

The main causes of urinary retention are obstructive, infectious/inflammatory, iatrogenic, and neurologic in nature; obstructive causes are the most common (Table 1).5

 Enlarge     Print

TABLE 1.

Selected Causes of Urinary Retention

CauseMenWomenBoth

Obstructive

Benign prostatic hyperplasia; meatal stenosis; paraphimosis; phimosis; prostate cancer

Organ prolapse (cystocele, rectocele, uterine prolapse); pelvic mass (gynecologic malignancy, uterine fibroid, ovarian cyst); retroverted impacted gravid uterus

Bladder calculi; bladder neoplasm; fecal impaction; gastrointestinal or retroperitoneal malignancy/mass; urethral strictures, foreign bodies, and stones

Infectious and inflammatory

Balanitis; prostatic abscess; prostatitis; posthitis

Acute vulvovaginitis; Behçet syndrome; vaginal lichen planus; vaginal lichen sclerosus; vaginal pemphigus

Aneurysmal dilation; bilharziasis (schistosomiasis); cystitis; echinococcosis; edema; Guillain-Barré syndrome; herpes simplex virus; Lyme disease; periurethral abscess; transverse myelitis; tubercular cystitis; urethritis; varicella-zoster virus

Iatrogenic/other

Fracture; laceration; penile constricting bands; penile trauma

Postpartum complication; urethral sphincter dysfunction (Fowler syndrome)

Disruption of posterior urethra and bladder neck in pelvic trauma; pharmacologic; postoperative complication; psychogenic


Note: For specific pharmacologic and neurologic causes of urinary retention, see Table 2 and Table 3, respectively.

Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):644.

TABLE 1.

Selected Causes of Urinary Retention

CauseMenWomenBoth

Obstructive

Benign prostatic hyperplasia; meatal stenosis; paraphimosis; phimosis; prostate cancer

Organ prolapse (cystocele, rectocele, uterine prolapse); pelvic mass (gynecologic malignancy, uterine fibroid, ovarian cyst); retroverted impacted gravid uterus

Bladder calculi; bladder neoplasm; fecal impaction; gastrointestinal or retroperitoneal malignancy/mass; urethral strictures, foreign bodies, and stones

Infectious and inflammatory

Balanitis; prostatic abscess; prostatitis; posthitis

Acute vulvovaginitis; Behçet syndrome; vaginal lichen planus; vaginal lichen sclerosus; vaginal pemphigus

Aneurysmal dilation; bilharziasis (schistosomiasis); cystitis; echinococcosis; edema; Guillain-Barré syndrome; herpes simplex virus; Lyme disease; periurethral abscess; transverse myelitis; tubercular cystitis; urethritis; varicella-zoster virus

Iatrogenic/other

Fracture; laceration; penile constricting bands; penile trauma

Postpartum complication; urethral sphincter dysfunction (Fowler syndrome)

Disruption of posterior urethra and bladder neck in pelvic trauma; pharmacologic; postoperative complication; psychogenic


Note: For specific pharmacologic and neurologic causes of urinary retention, see Table 2 and Table 3, respectively.

Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):644.

OBSTRUCTIVE

Benign prostatic hyperplasia is the most common obstructive cause of urinary retention, accounting for approximately 53% of cases6; a previous American Family Physician (AFP) article provides a detailed review of benign prostatic hyperplasia.7

Other obstructive causes in males include prostate cancer, phimosis, and paraphimosis; obstructive causes in females include pelvic organ prolapse of the bladder, rectum, or uterus. Both men and women can experience direct physical obstruction attributable to stones, urethral strictures, hematuria-related clot obstruction, and bladder cancer. Uncommonly, foreign bodies, either intraluminal or those causing extrinsic compression, can cause urinary retention. Additionally, fecal impaction, benign or malignant tumors, or other space-occupying pelvic masses can indirectly obstruct the urinary tract.5

INFECTIOUS AND INFLAMMATORY

Various infections can lead to edema of the urethra or bladder, resulting in acute urinary retention. Acute bacterial prostatitis, previously reviewed in an AFP article,8 and balanitis/posthitis5 are common infectious causes in men; vulvovaginal candidiasis and Behçet syndrome are infectious and inflammatory causes in women. In both sexes, urinary tract and other infections, including herpes zoster affecting the lumbosacral dermatome, can be triggers for urinary retention.5

IATROGENIC

The two main causes of iatrogenic urinary retention include postoperative side effects or are pharmacologic in nature. An estimated 2% of acute urinary retention cases admitted to a teaching hospital over a two-year period were attributed to medication side effects9; in another study, medications were determined to be the most likely cause of 12% of cases of chronic urinary retention.10  The most common medications that cause acute or chronic urinary retention have anticholinergic side effects (Table 211) that block the parasympathetic muscarinic receptors in the detrusor muscle, leading to impaired detrusor contractility. Alpha-adrenergic agonists, such as decongestants, increase tone in the prostate and bladder neck, whereas calcium channel blockers reduce smooth muscle contractility in the bladder.12 Nonsteroidal anti-inflammatory drugs inhibit prostaglandin synthesis, which, in theory, could lead to decreased detrusor muscle contraction.13

 Enlarge     Print

TABLE 2.

Selected Pharmacologic Agents Associated with Urinary Retention

ClassDrugs

Antiarrhythmics

Disopyramide (Norpace), procainamide, quinidine

Anticholinergics (selected)

Atropine, belladonna alkaloids, dicyclomine, flavoxate, glycopyrrolate (Robinul), hyoscyamine (Levsin), oxybutynin, propantheline, scopolamine

Antidepressants

Amitriptyline, amoxapine, doxepin, imipramine, maprotiline, nortriptyline (Pamelor)

Antihistamines (selected)

Brompheniramine, chlorpheniramine, cyproheptadine, diphenhydramine (Benadryl), hydroxyzine

Antihypertensives

Hydralazine, nifedipine

Antiparkinsonian agents

Amantadine, benztropine, bromocriptine (Parlodel), levodopa,* trihexyphenidyl

Antipsychotics

Chlorpromazine, fluphenazine, haloperidol, prochlorperazine, thioridazine, thiothixene

Hormonal agents

Estrogen, progesterone, testosterone

Muscle relaxants

Baclofen (Lioresal), cyclobenzaprine (Flexeril), diazepam (Valium)

Sympathomimetics (alpha-adrenergic agents)

Ephedrine, phenylephrine, pseudoephedrine

Sympathomimetics (beta-adrenergic agents)

Isoproterenol, metaproterenol, terbutaline

Miscellaneous

Amphetamines, carbamazepine (Tegretol), dopamine, mercurial diuretics, nonsteroidal anti-inflammatory drugs (e.g., indomethacin), opioid analgesics (e.g., morphine), vincristine


*—Levodopa is available only in combination drug products (e.g., carbidopa/levodopa [Sinemet]).

Adapted with permission from Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001;19(3):600.

TABLE 2.

Selected Pharmacologic Agents Associated with Urinary Retention

ClassDrugs

Antiarrhythmics

Disopyramide (Norpace), procainamide, quinidine

Anticholinergics (selected)

Atropine, belladonna alkaloids, dicyclomine, flavoxate, glycopyrrolate (Robinul), hyoscyamine (Levsin), oxybutynin, propantheline, scopolamine

Antidepressants

Amitriptyline, amoxapine, doxepin, imipramine, maprotiline, nortriptyline (Pamelor)

Antihistamines (selected)

Brompheniramine, chlorpheniramine, cyproheptadine, diphenhydramine (Benadryl), hydroxyzine

Antihypertensives

Hydralazine, nifedipine

Antiparkinsonian agents

Amantadine, benztropine, bromocriptine (Parlodel), levodopa,* trihexyphenidyl

Antipsychotics

Chlorpromazine, fluphenazine, haloperidol, prochlorperazine, thioridazine, thiothixene

Hormonal agents

Estrogen, progesterone, testosterone

Muscle relaxants

Baclofen (Lioresal), cyclobenzaprine (Flexeril), diazepam (Valium)

Sympathomimetics (alpha-adrenergic agents)

Ephedrine, phenylephrine, pseudoephedrine

Sympathomimetics (beta-adrenergic agents)

Isoproterenol, metaproterenol, terbutaline

Miscellaneous

Amphetamines, carbamazepine (Tegretol), dopamine, mercurial diuretics, nonsteroidal anti-inflammatory drugs (e.g., indomethacin), opioid analgesics (e.g., morphine), vincristine


*—Levodopa is available only in combination drug products (e.g., carbidopa/levodopa [Sinemet]).

Adapted with permission from Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001;19(3):600.

Postoperative urinary retention occurs in 2% to 14% of inpatient surgeries and significantly varies based on the type of anesthetic used in the procedure, but also on patient age, sex, and comorbidities. In two large analyses, the strongest risk factors for postoperative urinary retention included older age and the presence of lower urinary tract symptoms; use of a preoperative alpha blocker decreased this risk.14,15

NEUROLOGIC

Normal urinary function depends on storage of urine in the bladder at low intravesicular pressure without leakage and the ability to intermittently voluntarily and effectively empty the bladder. These processes depend on dynamic interactions between the central and peripheral autonomic and somatic nervous systems.16 Although miscommunication or interruption in these pathways more often results in urinary incontinence, comorbid or independent urinary retention can occur.17

Urinary retention can result from many neurologic conditions (Table 318). Over time, 25% to 60% of men and women with diabetes mellitus will develop diabetic cystopathy, which can lead to detrusor underactivity and urinary retention.19 In a 2010 cross-sectional study, approximately 25% of patients with multiple sclerosis reported needing intermittent catheterization.20 Patients with a new spinal cord injury experience spinal shock for one to 12 months postinjury, which can result in complete urinary retention. The majority of patients who have spinal cord injury with spinal shock–induced urinary retention will require management for incomplete bladder emptying, such as intermittent catheterization or a suprapubic tube, during this time frame.21 Many patients with spina bifida require anticholinergic medications to reduce bladder pressure. These medications can cause urinary retention, which requires intermittent catheterization to facilitate bladder emptying.22

 Enlarge     Print

TABLE 3.

Neurologic Causes of Urinary Retention and Voiding Dysfunction

Lesion typeCauses

Autonomic or peripheral nerve

Autonomic neuropathy, diabetes mellitus, Guillain-Barré syndrome, herpes zoster virus, Lyme disease, pelvic fracture, pernicious anemia, poliomyelitis, radical pelvic surgery, sacral agenesis, spinal cord trauma, tabes dorsalis

Brain

Cerebrovascular disease, concussion, multiple sclerosis, neoplasm or tumor, normal pressure hydrocephalus, Parkinson disease, Shy-Drager syndrome

Spinal cord

Dysraphic lesions, intervertebral disk disease, meningomyelocele, multiple sclerosis, spina bifida occulta, spinal cord hematoma or abscess, spinal cord trauma, spinal stenosis, spinovascular disease, transverse myelitis, tumors or masses of conus medullaris or cauda equina


Adapted with permission from Ellerkmann RM, McBride A. Management of obstructive voiding dysfunction. Drugs Today (Barc). 2003;39(7):515.

TABLE 3.

Neurologic Causes of Urinary Retention and Voiding Dysfunction

Lesion typeCauses

Autonomic or peripheral nerve

Autonomic neuropathy, diabetes mellitus, Guillain-Barré syndrome, herpes zoster virus, Lyme disease, pelvic fracture, pernicious anemia, poliomyelitis, radical pelvic surgery, sacral agenesis, spinal cord trauma, tabes dorsalis

Brain

Cerebrovascular disease, concussion, multiple sclerosis, neoplasm or tumor, normal pressure hydrocephalus, Parkinson disease, Shy-Drager syndrome

Spinal cord

Dysraphic lesions, intervertebral disk disease, meningomyelocele, multiple sclerosis, spina bifida occulta, spinal cord hematoma or abscess, spinal cord trauma, spinal stenosis, spinovascular disease, transverse myelitis, tumors or masses of conus medullaris or cauda equina


Adapted with permission from Ellerkmann RM, McBride A. Management of obstructive voiding dysfunction. Drugs Today (Barc). 2003;39(7):515.

Cerebrovascular accidents more commonly lead to urinary incontinence; however, a subset of patients experience urinary retention because of detrusor hyporeflexia or areflexia, and retention is more likely to occur when lesions are found in the brainstem. The incidence of urinary retention can range from 19% to 47% in the early recovery period; a study of 80 consecutive adults undergoing inpatient rehabilitation after a first ischemic stroke found that 23 had evidence of urinary retention on admission, but only four still did by the time of discharge.23

OTHER CAUSES

The risk of acute urinary retention increases during pregnancy and after the postpartum period. The incidence of acute urinary retention in pregnant women is about one in 200, and it is most common during weeks 9 through 16 of gestation. A significantly higher risk of developing acute urinary retention occurs in pregnant women who are 35 years or older, who have a retroverted uterus, or who experience preterm delivery during that pregnancy.24 In the postpartum period, the incidence of acute urinary retention rose to one in 10 women; risk factors included instrumental deliveries, labors lasting longer than 700 minutes, and applied fundal pressure during the second stage of labor. The correlation of acute urinary retention with epidural anesthesia, episiotomy, macrosomia, and primiparity is supported by conflicting data.2426

Self-inflicted causes of acute urinary retention include the use of external penile constricting devices used to maintain erections, as well as various other genitourinary traumas.5

Approach to Patients with Urinary Retention

The evaluation of the patient with suspected urinary retention should begin with a detailed history to elucidate the precise etiology, as summarized in Table 4.5 Initial evaluation should also include a thorough medication history, including use of over-the-counter medications and herbal supplements. The American Urological Association Symptom Index is a validated questionnaire that aims to quantify lower urinary tract symptoms in men relative to obstructive uropathy, often secondary to prostatic enlargement (https://www.aafp.org/afp/2014/1201/p769.html#afp20141201p769-f1).27

 Enlarge     Print

TABLE 4.

History and Physical Examination Findings That Suggest Etiologies of Urinary Retention

Potential etiologyHistoryPhysical examination

Men

Acute bacterial prostatitis

Fever, dysuria, rectal or perineal pain

Tender, boggy, warm prostate and possible penile discharge

Benign prostatic hyperplasia

Previous history of urinary retention

Enlarged, firm, nontender, non-nodular or normal prostate examination

Phimosis, paraphimosis, or edema from vacuum erection device

Pain, erythema, swelling of foreskin and/or penis

Edema of penis without retractable foreskin

Prostate cancer

Asymptomatic; weight loss; constitutional signs and symptoms

Normal or enlarged prostate with or without palpable nodules

Women

Cystocele; rectocele; uterine prolapse

Pelvic pressure; palpation of pelvic organ from vagina

Prolapse of bladder, rectum, or uterus

Uterine fibroid, pelvic mass or malignancy

Pelvic or lower abdominal pain, dysmenorrhea, bloating

Palpable uterus, ovaries, or adnexa

Vulvovaginitis

Vaginal discharge, vaginal itching, dysuria

Inflamed or erythematous vulva or vagina, vaginal discharge

Both

Advanced gastrointestinal tumor or malignancy

Constitutional symptoms; abdominal or pelvic pain or distention; rectal bleeding

Palpable abdominal or pelvic mass; positive fecal occult blood test; palpable rectal mass

Bladder tumor

Painless hematuria

Gross hematuria with or without clots

Cystitis, urethritis; urinary tract infection; sexually transmitted infection; herpes infection

Dysuria; hematuria; fever, back pain, constitutional symptoms; urethral discharge; genital rash or lesions; recent sexual activity

Suprapubic tenderness; costovertebral angle tenderness; urethral discharge; genital vesicles

Fecal impaction

Constipation

Abdominal or pelvic distention; dilated rectum; retained stool in vault

Neurogenic bladder

Existing or newly diagnosed neurologic disease; diabetic neuropathy; multiple sclerosis; Parkinson disease; stroke; overflow incontinence

Generalized or focal neurologic deficits relative to S1–S5 distribution


Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):647.

TABLE 4.

History and Physical Examination Findings That Suggest Etiologies of Urinary Retention

Potential etiologyHistoryPhysical examination

Men

Acute bacterial prostatitis

Fever, dysuria, rectal or perineal pain

Tender, boggy, warm prostate and possible penile discharge

Benign prostatic hyperplasia

Previous history of urinary retention

Enlarged, firm, nontender, non-nodular or normal prostate examination

Phimosis, paraphimosis, or edema from vacuum erection device

Pain, erythema, swelling of foreskin and/or penis

Edema of penis without retractable foreskin

Prostate cancer

Asymptomatic; weight loss; constitutional signs and symptoms

Normal or enlarged prostate with or without palpable nodules

Women

Cystocele; rectocele; uterine prolapse

Pelvic pressure; palpation of pelvic organ from vagina

Prolapse of bladder, rectum, or uterus

Uterine fibroid, pelvic mass or malignancy

Pelvic or lower abdominal pain, dysmenorrhea, bloating

Palpable uterus, ovaries, or adnexa

Vulvovaginitis

Vaginal discharge, vaginal itching, dysuria

Inflamed or erythematous vulva or vagina, vaginal discharge

Both

Advanced gastrointestinal tumor or malignancy

Constitutional symptoms; abdominal or pelvic pain or distention; rectal bleeding

Palpable abdominal or pelvic mass; positive fecal occult blood test; palpable rectal mass

Bladder tumor

Painless hematuria

Gross hematuria with or without clots

Cystitis, urethritis; urinary tract infection; sexually transmitted infection; herpes infection

Dysuria; hematuria; fever, back pain, constitutional symptoms; urethral discharge; genital rash or lesions; recent sexual activity

Suprapubic tenderness; costovertebral angle tenderness; urethral discharge; genital vesicles

Fecal impaction

Constipation

Abdominal or pelvic distention; dilated rectum; retained stool in vault

Neurogenic bladder

Existing or newly diagnosed neurologic disease; diabetic neuropathy; multiple sclerosis; Parkinson disease; stroke; overflow incontinence

Generalized or focal neurologic deficits relative to S1–S5 distribution


Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):647.

Physical examination should include a complete abdominal assessment, including palpation and percussion of the bladder and abdominal/pelvic organs; evaluation for flank tenderness; a digital rectal examination in men to assess prostate size with or without nodularity and the presence or absence of rectal masses; a complete pelvic examination in women; and a neurologic evaluation to assess strength, sensation, muscle tone, and reflexes relative to lower thoracic, lumbar, and sacral spinal levels.5

Testing should include a postvoid residual (PVR) urine evaluation, which is a simple, noninvasive, and cost-effective volume measurement of urine within the bladder that can be performed with ultrasonography in the office. To date, there is no consensus on the cutoff volume to define acute urinary retention. Some studies posit that the bladder can be percussed when it contains 150 mL of urine and palpated with greater than 200 mL.5 No evidence supports a specific PVR threshold for patients with chronic urinary retention; however, the American Urological Association has recommended using a value greater than 300 mL that has persisted for at least six months and has been documented on two separate occasions.28 Patients with chronic urinary retention should be referred to a urologist if they are bothered by related symptoms or have evidence of renal or infectious complications resulting from retained urine. If PVR evaluation cannot be obtained or if it is thought to be inaccurate, patients with suspected urinary retention should be catheterized for decompression of the bladder and accurate measurement of stored urine.

Table 5 reviews additional diagnostic testing that may be indicated in the evaluation of a patient with urinary retention.5

 Enlarge     Print

TABLE 5.

Diagnostic Testing in Patients with Urinary Retention

Test typeDiagnostic testRationale

Laboratory

Prostate-specific antigen

May be elevated in prostate cancer, benign prostatic hyperplasia, prostatitis, and in the setting of acute urinary retention

Serum blood glucose

Evaluate for undiagnosed or uncontrolled diabetes mellitus in neurogenic bladder

Serum blood urea nitrogen, creatinine, electrolytes

Evaluate for renal failure from lower urinary tract obstruction

Urinalysis

Evaluate for infection, hematuria, proteinuria, glucosuria

Imaging studies

Magnetic resonance imaging of the spine

Evaluate for lumbosacral disk herniation, cauda equina syndrome, spinal tumors, spinal cord compression, multiple sclerosis

Magnetic resonance imaging or computed tomography of the brain

Evaluate for intracranial lesion, including tumor, stroke, multiple sclerosis (magnetic resonance imaging preferred in multiple sclerosis)

Pelvic ultrasonography; computed tomography of the abdomen and pelvis

Evaluate for suspected pelvic, abdominal, or retroperitoneal mass or malignancy causing extrinsic bladder neck compression

Renal and bladder ultrasonography

Measure postvoid residual urine; evaluate for bladder and urethral stones, hydronephrosis, and upper urinary tract disease

Other

Cystoscopy, retrograde cystourethrography

Evaluate for suspected bladder tumor and bladder or urethral stones or strictures

Urodynamic studies (e.g., uroflowmetry, cystometry, electromyography, urethral pressure profile, video urodynamics, pressure flow studies of micturition)

Evaluate bladder function (detrusor muscle and sphincter) in patients with neurogenic bladder to help guide management


Note: Imaging studies and diagnostic procedures are guided by the clinical context and suspected diagnoses.

Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):648.

TABLE 5.

Diagnostic Testing in Patients with Urinary Retention

Test typeDiagnostic testRationale

Laboratory

Prostate-specific antigen

May be elevated in prostate cancer, benign prostatic hyperplasia, prostatitis, and in the setting of acute urinary retention

Serum blood glucose

Evaluate for undiagnosed or uncontrolled diabetes mellitus in neurogenic bladder

Serum blood urea nitrogen, creatinine, electrolytes

Evaluate for renal failure from lower urinary tract obstruction

Urinalysis

Evaluate for infection, hematuria, proteinuria, glucosuria

Imaging studies

Magnetic resonance imaging of the spine

Evaluate for lumbosacral disk herniation, cauda equina syndrome, spinal tumors, spinal cord compression, multiple sclerosis

Magnetic resonance imaging or computed tomography of the brain

Evaluate for intracranial lesion, including tumor, stroke, multiple sclerosis (magnetic resonance imaging preferred in multiple sclerosis)

Pelvic ultrasonography; computed tomography of the abdomen and pelvis

Evaluate for suspected pelvic, abdominal, or retroperitoneal mass or malignancy causing extrinsic bladder neck compression

Renal and bladder ultrasonography

Measure postvoid residual urine; evaluate for bladder and urethral stones, hydronephrosis, and upper urinary tract disease

Other

Cystoscopy, retrograde cystourethrography

Evaluate for suspected bladder tumor and bladder or urethral stones or strictures

Urodynamic studies (e.g., uroflowmetry, cystometry, electromyography, urethral pressure profile, video urodynamics, pressure flow studies of micturition)

Evaluate bladder function (detrusor muscle and sphincter) in patients with neurogenic bladder to help guide management


Note: Imaging studies and diagnostic procedures are guided by the clinical context and suspected diagnoses.

Adapted with permission from Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):648.

Management of Patients with Urinary Retention

ACUTE URINARY RETENTION

In patients with suggestive history or symptoms, physicians should first use physical examination and/or imaging to confirm that the patient is retaining urine (Figure 1). The physician should then assess for urethral access by asking patients whether they have a history of urethral stricture, urethral injury, bladder or urethral surgery, or pelvic/perineal trauma that may have altered their urethral anatomy. It may be advisable to urgently refer these patients for urologic evaluation rather than attempting catheterization, particularly if patients note a history of being difficult to catheterize. These patients may benefit from an alternative catheter, such as a coudé tip, an endoscopic catheter placement via cystoscopy, or suprapubic catheter placement rather than the traditional 16 Fr catheter. Suprapubic catheters improve patient comfort and decrease bacteriuria and the need for recatheterization in those who require catheterization for up to 14 days.29

 Enlarge     Print

FIGURE 1.

Management of acute urinary retention.


FIGURE 1.

Management of acute urinary retention.

Catheterization of patients with acute urinary retention should be attempted by experienced physicians because patients are usually experiencing significant discomfort; multiple unsuccessful attempts to place the catheter may increase the risk of urethral injury.30 A Cochrane review found that catheters coated with silver alloy do not prevent catheter-acquired urinary tract infections, and antibiotic-impregnated catheters produce statistically significant but clinically unimportant reductions.31 After the catheter is placed, the bladder should be allowed to drain continuously for at least three days.

Physicians should be aware that high-volume urinary retention can sometimes cause ureteral obstruction and, consequently, acute renal injury. Therefore, rapid decompression of the bladder can occasionally lead to a postobstructive diuresis and hematuria. Physicians should be aware of this rare potential complication and should monitor patients closely for electrolyte abnormalities, dehydration, and hypotension.

Starting an alpha-blocker medication such as tamsulosin (Flomax) at the time of catheter insertion or certainly before removal increases the likelihood of a successful voiding trial, although it may not prevent recurrent urinary retention or the need for future surgical intervention. Most experts recommend a voiding trial after the catheter has been in place for three to seven days, which should be sufficient for resolution of an iatrogenic or temporary condition.3237 Patients who fail a voiding trial after catheter removal, who have a PVR greater than 300 mL, or who reported bothersome urinary symptoms before the retention episode should be referred to a urologist within two to three weeks for evaluation.

CHRONIC URINARY RETENTION

Chronic urinary retention should be managed based on its underlying cause. For patients with non-neurologic chronic urinary retention, the American Urological Association has proposed a treatment algorithm that recommends classifying patients with chronic urinary retention first by risk and then by symptoms (Figure 228). Patients with high-risk chronic urinary retention have associated findings of hydronephrosis on imaging, stage 3 chronic kidney disease, or recurrent culture-proven urinary tract infection or urosepsis. Patients with symptomatic chronic urinary retention will generally report moderate to severe urinary symptoms on the American Urological Association Symptom Index and/or have a recent history of catheterization for urinary retention. All of these patients should be reassessed periodically for changes in risk or symptoms.28

 Enlarge     Print

FIGURE 2.

American Urological Association treatment algorithm for non-neurologic chronic urinary retention. (GFR = glomerular filtration rate; UTI = urinary tract infection)

Adapted with permission from Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198(1):156.


FIGURE 2.

American Urological Association treatment algorithm for non-neurologic chronic urinary retention. (GFR = glomerular filtration rate; UTI = urinary tract infection)

Adapted with permission from Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198(1):156.

Persons with urinary retention related to an underlying neurologic cause (“neurogenic bladder”), including those with spinal cord injuries, have a significantly higher risk of infectious or renal morbidity from retained urine.38 Given the additional risk of these and other neurologic conditions, such as multiple sclerosis and Parkinson disease, these patients should be followed in conjunction with a neurologist and urologist.

This article updates a previous article on this topic by Selius and Subedi.5

Data Sources: A PubMed search was completed using the key terms acute urinary retention and chronic urinary retention. The Cochrane Database of Systematic Reviews was searched using the key term urinary retention. Essential Evidence Plus, the U.S. Preventive Services Task Force, the Agency for Healthcare Research and Quality, and the National Guideline Clearinghouse were also searched. Search dates: April through July 2017.

The Authors

show all author info

DAVID C. SERLIN, MD, is an assistant professor in the Department of Family Medicine at the University of Michigan Medical School, Ann Arbor....

JOEL J. HEIDELBAUGH, MD, is a clinical professor in the Departments of Family Medicine and Urology at the University of Michigan Medical School.

JOHN T. STOFFEL, MD, is a professor in the Department of Urology at the University of Michigan Medical School.

Address correspondence to David C. Serlin, MD, Department of Family Medicine, University of Michigan Medical School, 300 North Ingalls St., NI4C06, Ann Arbor, MI 48109-5435. Reprints are not available from the authors.

Author disclosure: Dr. Stoffel reports receiving grant funding from Ipsen and Cogentix in relation to treatment of neurogenic overactive bladder and stress incontinence; the other authors have no relevant financial affiliations.

References

show all references

1. Fitzpatrick JM, Kirby RS. Management of acute urinary retention. BJU Int. 2006;97(suppl 2):16–20, discussion 21–22....

2. Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol. 1999;162(2):376–382.

3. Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158(2):481–487.

4. Klarskov P, Andersen JT, Asmussen CF, et al. Acute urinary retention in women: a prospective study of 18 consecutive cases. Scand J Urol Nephrol. 1987;21(1):29–31.

5. Selius BA, Subedi R. Urinary retention in adults: diagnosis and initial management. Am Fam Physician. 2008;77(5):643–650.

6. Choong S, Emberton M. Acute urinary retention. BJU Int. 2000;85(2):186–201.

7. Pearson R, Williams PM. Common questions about the diagnosis and management of benign prostatic hyperplasia. Am Fam Physician. 2014;90(11):769–774.

8. Coker TJ, Dierfeldt DM. Acute bacterial prostatitis: diagnosis and management. Am Fam Physician. 2016;93(2):114–120.

9. Murray K, Massey A, Feneley RC. Acute urinary retention—a urodynamic assessment. Br J Urol. 1984;56(5):468–473.

10. Kurasawa G, Kotani K, Kurasawa M, Takama N, Orimo K. Causes of chronic retention of urine in the primary care setting. Intern Med. 2005;44(7):761–762.

11. Curtis LA, Dolan TS, Cespedes RD. Acute urinary retention and urinary incontinence. Emerg Med Clin North Am. 2001;19(3):600.

12. Verhamme KM, Sturkenboom MC, Stricker BH, Bosch R. Drug-induced urinary retention: incidence, management and prevention. Drug Saf. 2008;31(5):373–388.

13. Verhamme KM, Dieleman JP, Van Wijk MA, et al. Nonsteroidal anti-inflammatory drugs and increased risk of acute urinary retention. Arch Intern Med. 2005;165(13):1547–1551.

14. Wu AK, Auerbach AD, Aaronson DS. National incidence and outcomes of postoperative urinary retention in the Surgical Care Improvement Project. Am J Surg. 2012;204(2):167–171.

15. Mason SE, Scott AJ, Mayer E, Purkayastha S. Patient-related risk factors for urinary retention following ambulatory general surgery: a systematic review and meta-analysis. Am J Surg. 2016;211(6):1126–1134.

16. Clemens JQ. Basic bladder neurophysiology. Urol Clin North Am. 2010;37(4):487–494.

17. Fowler CJ, O'Malley KJ. Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry. 2003;74(suppl 4):iv27–iv31.

18. Ellerkmann RM, McBride A. Management of obstructive voiding dysfunction. Drugs Today (Barc). 2003;39(7):515.

19. Kebapci N, Yenilmez A, Efe B, Entok E, Demirustu C. Bladder dysfunction in type 2 diabetic patients. Neurourol Urodyn. 2007;26(6):814–819.

20. Mahajan ST, Patel PB, Marrie RA. Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry. J Urol. 2010;183(4):1432–1437.

21. Ditunno JF, Little JW, Tessler A, Burns AS. Spinal shock revisited: a four-phase model. Spinal Cord. 2004;42(7):383–395.

22. Mourtzinos A, Stoffel JT. Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood. Urol Clin North Am. 2010;37(4):527–535.

23. Kong KH, Young S. Incidence and outcome of poststroke urinary retention: a prospective study. Arch Phys Med Rehabil. 2000;81(11):1464–1467.

24. Kekre AN, Vijayanand S, Dasgupta R, Kekre N. Postpartum urinary retention after vaginal delivery. Int J Gynaecol Obstet. 2011;112(2):112–115.

25. Pifarotti P, Gargasole C, Folcini C, et al. Acute postpartum urinary retention: analysis of risk factors, a case-control study. Arch Gynecol Obstet. 2014;289(6):1249–1253.

26. Mulder FE, Schoffelmeer MA, Hakvoort RA, et al. Risk factors for postpartum urinary retention: a systematic review and meta-analysis. BJOG. 2012;119(12):1440–1446.

27. Barry MJ, Fowler FJ Jr, O'Leary MP, et al.; Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 2017;197(2S):S189–S197.

28. Stoffel JT, Peterson AC, Sandhu JS, Suskind AM, Wei JT, Lightner DJ. AUA white paper on nonneurogenic chronic urinary retention: consensus definition, treatment algorithm, and outcome end points. J Urol. 2017;198(1):153–160.

29. Kidd EA, Stewart F, Kassis NC, Hom E, Omar MI. Urethral (indwelling or intermittent) or suprapubic routes for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2015;(12):CD004203.

30. Bhatt NR, Davis NF, Quinlan MR, et al. A prospective audit on the effect of training and educational workshops on the incidence of urethral catheterization injuries. Can Urol Assoc J. 2017;11(7):E302–E306.

31. Lam TB, Omar MI, Fisher E, Gillies K, MacLennan S. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014;(9):CD004013.

32. Boettcher S, Brandt AS, Roth S, Mathers MJ, Lazica DA. Urinary retention: benefit of gradual bladder decompression—myth or truth? A randomized controlled trial. Urol Int. 2013;91(2):140–144.

33. Lucas MG, Stephenson TP, Nargund V. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia. BJU Int. 2005;95(3):354–357.

34. Yoon PD, Chalasani V, Woo HH. Systematic review and meta-analysis on management of acute urinary retention. Prostate Cancer Prostatic Dis. 2015;18(4):297–302.

35. Fisher E, Subramonian K, Omar MI. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. Cochrane Database Syst Rev. 2014;(6):CD006744.

36. McNeill SA, Hargreave TB; Members of the Alfaur Study Group. Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol. 2004;171(6 pt 1):2316–2320.

37. Emberton M, Fitzpatrick JM. The Reten-World survey of the management of acute urinary retention: preliminary results. BJU Int. 2008;101(suppl 3):27–32.

38. Stoffel JT. Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl Androl Urol. 2016;5(1):127–135.

 

 

Copyright © 2018 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact afpserv@aafp.org for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions


More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Oct 15, 2019

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article